A CHOC-led study on the frequency of bounce house injuries reveals the safety concerns and the need for prevention tactics.
In a webinar with U.S. News & World Report, Dr. Anthony Chang discusses how the COVID-19 pandemic propelled medical innovation at CHOC.
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
The Inaugural CHOC and UCI Rare Disease Symposium & Family Conference will take place on Friday, March 11, 2022, from 10:30 a.m. to 3 p.m.
This study is one of the first to stratify injury severity based on the type of surgical treatment required.